BSE:535217

Stock Analysis Report

Executive Summary

HPC Biosciences Limited operates in the agriculture industry in India.


Snowflake Analysis

Flawless balance sheet with questionable track record.


Similar Companies

Share Price & News

How has HPC Biosciences's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 535217 has not had significant price volatility in the past 3 months.


Market Performance


7 Day Return

0%

535217

14.8%

IN Food

8.9%

IN Market


1 Year Return

n/a

535217

-3.8%

IN Food

-30.6%

IN Market

Return vs Industry: Insufficient data to determine how 535217 performed against the Indian Food industry.

Return vs Market: Insufficient data to determine how 535217 performed against the Indian Market.


Shareholder returns

535217IndustryMarket
7 Day0%14.8%8.9%
30 Day0%-13.9%-24.8%
90 Dayn/a-12.3%-29.4%
1 Yearn/a-2.4%-3.8%-29.2%-30.6%
3 Yearn/a43.8%39.4%-17.0%-21.5%
5 Year-43.7%-43.7%84.2%75.2%-5.4%-10.4%

Price Volatility Vs. Market

How volatile is HPC Biosciences's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is HPC Biosciences undervalued compared to its fair value and its price relative to the market?

747.34x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 535217 (₹25.95) is trading above our estimate of fair value (₹1.39)

Significantly Below Fair Value: 535217 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 535217 is poor value based on its PE Ratio (747.3x) compared to the Food industry average (12.5x).

PE vs Market: 535217 is poor value based on its PE Ratio (747.3x) compared to the Indian market (12.5x).


Price to Earnings Growth Ratio

PEG Ratio: Insufficient data to calculate 535217's PEG Ratio to determine if it is good value.


Price to Book Ratio

PB vs Industry: 535217 is overvalued based on its PB Ratio (13.2x) compared to the IN Food industry average (0.9x).


Next Steps

Future Growth

How is HPC Biosciences forecast to perform in the next 1 to 3 years based on estimates from 0 analysts?

21.1%

Forecasted Food, Beverage & Tobacco industry annual growth in earnings


In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as HPC Biosciences has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.


Next Steps

Past Performance

How has HPC Biosciences performed over the past 5 years?

-20.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 535217 has high quality earnings.

Growing Profit Margin: 535217 became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: 535217's earnings have declined by -20.8% per year over the past 5 years.

Accelerating Growth: 535217 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 535217 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Food industry (20.6%).


Return on Equity

High ROE: 535217's Return on Equity (2.6%) is considered low.


Next Steps

Financial Health

How is HPC Biosciences's financial position?


Financial Position Analysis

Short Term Liabilities: 535217's short term assets (₹240.0M) exceed its short term liabilities (₹4.4M).

Long Term Liabilities: 535217 has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: 535217 is debt free.

Reducing Debt: 535217 has no debt compared to 5 years ago when its debt to equity ratio was 1.7%.

Debt Coverage: 535217 has no debt, therefore it does not need to be covered by operating cash flow.

Interest Coverage: 535217 has no debt, therefore coverage of interest payments is not a concern.


Balance Sheet

Inventory Level: 535217 has a low level of unsold assets or inventory.

Debt Coverage by Assets: Insufficient data to determine if 535217's debt is covered by short term assets.


Next Steps

Dividend

What is HPC Biosciences's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 535217's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 535217's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 535217's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 535217's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: Insufficient data to calculate payout ratio to determine if its dividend payments are covered by earnings.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 535217's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

6.2yrs

Average board tenure


CEO

Tarun Chauhan (38yo)

no data

Tenure

₹426,000

Compensation

Mr. Tarun Chauhan has been a Whole-Time Director of hpc BIOSCIENCES LIMITED since October 1, 2011. Mr. Chauhan is the Promoter of hpc BIOSCIENCES LIMITED. He is responsible for day to day affairs of hpc BI ...


CEO Compensation Analysis

Compensation vs Market: Tarun's total compensation ($USD5.87K) is below average for companies of similar size in the Indian market ($USD49.62K).

Compensation vs Earnings: Tarun's compensation has been consistent with company performance over the past year.


Board Members

NamePositionTenureCompensationOwnership
Tarun Chauhan
Whole-Time Directorno data₹426.00k0.058% 2.4m
Madhu Anand
CFO & Director8.42yrsno data21.87% 905.8m
- Mumtaj
Additional Independent Director4yrsno datano data
Kishori Gupta
Independent Director2yrsno datano data

6.2yrs

Average Tenure

44yo

Average Age

Experienced Board: 535217's board of directors are considered experienced (6.2 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

HPC Biosciences Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: HPC Biosciences Limited
  • Ticker: 535217
  • Exchange: BSE
  • Founded: 2002
  • Industry: Agricultural Products
  • Sector: Food, Beverage & Tobacco
  • Market Cap: ₹4.142b
  • Shares outstanding: 159.60m
  • Website: https://www.hpcbiosciences.com

Number of Employees


Location

  • HPC Biosciences Limited
  • Pooja Complex
  • Office No. 109, First Floor
  • New Delhi
  • Delhi
  • 110092
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
535217BSE (Mumbai Stock Exchange)YesEquity SharesININRMar 2013

Biography

HPC Biosciences Limited operates in the agriculture industry in India. The company manufactures and sells wheat, rice, pulses, and vegetables. It operates orchards of mango, guava, pomegranate, and various flowers primarily roses; and farms of trees, including poplar, eucalyptus, kadam, mentha, and bamboos. HPC Biosciences Limited was incorporated in 2002 and is based in New Delhi, India. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/03/01 13:10
End of Day Share Price2019/12/03 00:00
Earnings2019/09/30
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.